Literature DB >> 19498355

Bone seems susceptible to range of drugs.

Charlotte Schubert.   

Abstract

Mesh：

Year:  2009        PMID： 19498355     DOI： 10.1038/nm0609-588

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

1.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

2.  Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Authors:  Stuart J Warden; Alexander G Robling; Megan S Sanders; Michael M Bliziotes; Charles H Turner
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

3.  Stomaching calcium for bone health.

Authors:  Brendan F Boyce
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

4.  Impaired gastric acidification negatively affects calcium homeostasis and bone mass.

Authors:  Thorsten Schinke; Arndt F Schilling; Anke Baranowsky; Sebastian Seitz; Robert P Marshall; Tilman Linn; Michael Blaeker; Antje K Huebner; Ansgar Schulz; Ronald Simon; Matthias Gebauer; Matthias Priemel; Uwe Kornak; Sandra Perkovic; Florian Barvencik; F Timo Beil; Andrea Del Fattore; Annalisa Frattini; Thomas Streichert; Klaus Pueschel; Anna Villa; Klaus-Michael Debatin; Johannes M Rueger; Anna Teti; Jozef Zustin; Guido Sauter; Michael Amling
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

5.  Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.

Authors:  Vijay K Yadav; Je-Hwang Ryu; Nina Suda; Kenji F Tanaka; Jay A Gingrich; Günther Schütz; Francis H Glorieux; Cherie Y Chiang; Jeffrey D Zajac; Karl L Insogna; J John Mann; Rene Hen; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

6.  Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen.

Authors:  Terrie-Anne Cock; Jonathan Back; Florent Elefteriou; Gérard Karsenty; Philippe Kastner; Susan Chan; Johan Auwerx
Journal:  EMBO Rep       Date:  2004-09-10       Impact factor: 8.807

Review 7.  Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.

Authors:  E M Haney; S J Warden
Journal:  J Musculoskelet Neuronal Interact       Date:  2008 Apr-Jun       Impact factor: 2.041

8.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

9.  PPAR-gamma regulates osteoclastogenesis in mice.

Authors:  Yihong Wan; Ling-Wa Chong; Ronald M Evans
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440
  9 in total
  2 in total

1.  Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus.

Authors:  Zeina A Habib; Suzanne L Havstad; Karen Wells; George Divine; Manel Pladevall; L Keoki Williams
Journal:  J Clin Endocrinol Metab       Date:  2010-01-08       Impact factor: 5.958

2.  Depressive symptoms and bone mineral density among police officers in a northeastern US City.

Authors:  Luenda E Charles; Desta Fekedulegn; Diane B Miller; Jean Wactawski-Wende; John M Violanti; Michael E Andrew; Cecil M Burchfiel
Journal:  Glob J Health Sci       Date:  2012-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.